In 2023, the United States led the global export of insulin with a value of $1.3456 billion. Denmark followed with $0.30728 billion, while India reported significant growth, reaching $0.030789 billion. France experienced a decrease of 6.36%, whereas Malaysia and China saw moderate increases of 3.91% and 0.28% respectively. Noteworthy, Singapore showed a 14.65% boost in exports. Conversely, nations like the Netherlands (-3.59%) and Ukraine (-8.36%) faced declines. Over the last two years, the majority of countries exhibited slight increments, with some exceptions indicating fluctuating trends.
Future trends to watch include the potential expansion in Asian markets, notably India and Singapore, driven by increased capacity and innovation. Continuous monitoring of regulatory changes, especially in major markets like the US and Europe, is crucial. Rising demand for insulin in emerging economies may shift export dynamics, influencing future growth patterns favorably.
Top countries in Export of Insulin by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 1,345,600,000 | 2023 | +3.01% | +2.92% | View data |
| 2 | 2 Denmark | 307,280,000 | 2023 | -3.1% | +0.21% | View data |
| 3 | 3 India | 30,789,000 | 2023 | +2.77% | +5.53% | View data |
| 4 | 4 France | 16,833,000 | 2023 | -2.98% | -6.36% | View data |
| 5 | 5 Malaysia | 14,605,000 | 2023 | +6.53% | +3.91% | View data |
| 6 | 6 China | 14,035,000 | 2023 | +1.82% | +0.28% | View data |
| 7 | 7 Portugal | 5,518,800 | 2023 | +6.04% | +2.94% | View data |
| 8 | 8 Netherlands | 5,197,800 | 2023 | -2.62% | -3.59% | View data |
| 9 | 9 Singapore | 3,673,500 | 2023 | +5.47% | +14.65% | View data |
| 10 | 10 United Arab Emirates | 1,500,500 | 2023 | +4.68% | +6.02% | View data |
